Outsmarting the Virus

Abstract

Variants in the SARS-CoV-2 virus control infectivity, severity, and immunity. Against this hydra, the best modes of defense are multipronged. John Hewitt takes stock of currently available SARS-CoV-2 therapies; in particular, he notes new combination therapies that strike at the heart of the virus to complement vaccinations and provide a defense the virus cannot outsmart.